Status:
RECRUITING
Pathological Type，Gene Mutation and Clinical Characteristics of Unilateral Primary Aldosteronism
Lead Sponsor:
Qifu Li
Conditions:
Primary Aldosteronism
Eligibility:
All Genders
18-80 years
Brief Summary
1. Aim to investigate the pathological feature of UPA in Asians 2. To clarify the relationship between pathology, clinical phenotype, genetic mutation and surgical outcome of UPA in Asians. 3. To expl...
Detailed Description
The multi-center expert team led by Tracy Ann Williams formulated the International Consensus on the Pathological Diagnosis of Unilateral aldehyde disease, which standardized the pathological classifi...
Eligibility Criteria
Inclusion
- No gender limitation;
- Age 18-80 years old;
- The patient was diagnosed with UPA and underwent total adrenal resection.
Exclusion
- Bilateral disease
- Partial of no biochemical response in follow-up
- partial adrenalectomy
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06597630
Start Date
December 1 2023
End Date
December 31 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qifu Li, PhD
Chongqing, Chongqing Municipality, China, 400016